Skip to content

Author

Volta Kellik Setiawan

We have 4 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Progress in antiviral and vaccine strategies against hantavirus: Current advances and future perspectives

Hantaviruses are rodent-associated zoonotic RNA viruses responsible for hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS), two clinically distinct diseases characterized by vascular dysfunction and potentially severe organ failure. Their geographic distribution, antigenic diver...

A. Khairullah, M. R. Afnani, B. Pratama et al. · 0 citations
Aug 2026

Expression-Guided Immunoinformatics Design of a Recombinant Multi-Epitope Vaccine Candidate for Triple-Negative Breast Cancer Incorporating a MyD88-Derived Immunomodulatory Domain

Triple-negative breast cancer (TNBC) remains a major therapeutic challenge because of its aggressive behavior, molecular heterogeneity, and limited subtype-specific targets. This study used an integrated immunoinformatics workflow to design a recombinant tumor-associated antigen-derived multi-epitope vaccine based on M...

M. R. Afnani, Volta Kellik Setiawan, Anwar Rovik · 0 citations
Open access Jul 2026

In silico identification of organosulfur compounds from Allium ascalonicum L. as potential inhibitors of influenza A (H5N1): integrated DFT, docking, and molecular dynamics analysis

It is suggested that shallot-derived organosulfur compounds, especially γ-glutamyl-S-propenylcysteine, exhibit potential for interaction with H5N1 viral targets and may warrant further investigation as antiviral candidates.

Rangga Adhi Prastika, Alifaghi Pahlevi Ervianto Putra, Muhammad Alesha Fadhana et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.